LEX Diagnostics Ltd

LEX Diagnostics is a company that specializes in molecular diagnostics, specifically point-of-care testing. Their core product is the LEX VELO system, a compact and automated platform that uses PCR technology to detect and differentiate respiratory pathogens such as Flu A, Flu B, and COVID-19. The system provides lab-quality results in under 10 minutes, with positive results available in as little as 6 minutes, and requires minimal hands-on time. The VELO system is designed for use in healthcare facilities, including physician's offices, pharmacies, and urgent care facilities, and has received FDA 510(k) clearance and CLIA waiver. The company plans to expand its test menu to include other pathogens such as StrepA, RSV, and STIs.

LEX Diagnostics is a tight knit team working hard to widen access to molecular diagnostics and reduce the burden of infectious disease on the world. We aim to develop and manufacture a true PCR diagnostic focussed specifically on the needs of healthcare professionals and sell it at a price low enough to replace antigen tests in clinical settings.